05.25.22
Manatt shares updates on state cost growth benchmarking programs & and other data-driven initiatives to contain health care cost growth.
05.23.22
Youth with behavioral health needs—particularly those receiving residential care—are at high risk of homelessness.
05.19.22
States have increasingly sought to use Medicaid to address social drivers of health—factors such as healthy living environments or nutritious food that are outside of traditional health care but are among the largest contributors to health outcomes.
05.18.22
Last week, the Center for Drug Evaluation and Research at the Food and Drug Administration launched a new program to coordinate and centralize CDER’s rare disease activities.
05.09.22
The Centers for Medicare & Medicaid Services released the final 2023 Notice of Benefit and Payment Parameters, the annual rule outlining key policies for the individual and group health insurance markets for plan year 2023 and beyond.
05.05.22
The United States continues to face a behavioral health crisis that has worsened due to the COVID-19 pandemic.
04.28.22
After years of government skepticism and enforcement activity targeting physician-owned medical device companies, a recent favorable advisory opinion by the Office of Inspector General for the U.S. Department of Health & Human Services may offer a degree of comfort to certain manufacturers of ...
04.21.22
Last week, in the midst of the Biden Administration’s coordinated release of more than 90 “Equity Action Plans” by various federal agencies, the FDA issued a new draft guidance on enhancing clinical trial diversity.
04.20.22
Long-standing structural racism and related health inequities experienced by people of color further laid bare by the COVID-19 pandemic have mobilized many state leaders to take action on health equity.
04.14.22
On April 7, the Centers for Medicare & Medicaid Services released its highly anticipated final National Coverage Determination (NCD) for Aduhelm and other similar therapies in the pipeline for Alzheimer’s disease.
